LeadIQ logo
Learn more at LeadIQ.com

Insights

New Product Launches Neurocrine Biosciences recently launched INGREZZA SPRINKLE, a new formulation targeting adults with tardive dyskinesia and Huntington's disease-associated chorea who have difficulty swallowing. This presents a sales opportunity to promote and sell this innovative product to healthcare providers and institutions.

Leadership Change With the appointment of Kyle Gano as the new CEO, Neurocrine Biosciences is undergoing a leadership transition. This change can be leveraged by sales teams to establish new relationships, explore potential collaborations, and introduce existing and upcoming products under new leadership.

Investor Interest Recent investments from Mediolanum International Funds Ltd and Weiss Asset Management Group indicate growing investor confidence in Neurocrine Biosciences. Sales professionals can use this positive market sentiment to engage with potential investors and showcase the company's growth potential.

Retirement of CEO The retirement of Kevin Gorman, the long-standing CEO of Neurocrine Biosciences, signifies a significant transition period for the company. This presents an opportunity for sales representatives to connect with key stakeholders, understand evolving strategies, and position products effectively in the market under new leadership.

Market Expansion Neurocrine Biosciences' expansion of its product portfolio and continuous development of treatments for neurological and neuroendocrine disorders indicate a growing market presence. Sales teams can capitalize on this expansion by exploring new partnerships, entering new markets, and increasing sales channels to reach a wider patient base.

Similar companies to Neurocrine Biosciences

Neurocrine Biosciences Tech Stack

Neurocrine Biosciences uses 8 technology products and services including iCIMS, Veeam, Microsoft Word, and more. Explore Neurocrine Biosciences's tech stack below.

  • iCIMS
    Applicant Tracking Systems
  • Veeam
    Backup And Recovery
  • Microsoft Word
    Editors
  • Microsoft PowerPoint
    Editors
  • AMP
    Javascript Frameworks
  • scikit-learn
    Machine Learning
  • iOS
    Programming Languages
  • Linux
    Programming Languages

Media & News

Neurocrine Biosciences's Email Address Formats

Neurocrine Biosciences uses at least 1 format(s):
Neurocrine Biosciences Email FormatsExamplePercentage
FLast@neurocrine.comJDoe@neurocrine.com
92%
First.Last@neurocrine.comJohn.Doe@neurocrine.com
6%
FLast@neurocrine.comJDoe@neurocrine.com
1%
FLast@neurocrine.comJDoe@neurocrine.com
1%

Frequently Asked Questions

Where is Neurocrine Biosciences's headquarters located?

Minus sign iconPlus sign icon
Neurocrine Biosciences's main headquarters is located at San Diego, California US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Neurocrine Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Neurocrine Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neurocrine Biosciences's stock symbol?

Minus sign iconPlus sign icon
Neurocrine Biosciences is a publicly traded company; the company's stock symbol is NBIX.

What is Neurocrine Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Neurocrine Biosciences's official website is neurocrine.com and has social profiles on LinkedIn.

How much revenue does Neurocrine Biosciences generate?

Minus sign iconPlus sign icon
As of November 2024, Neurocrine Biosciences's annual revenue reached $1.9B.

What is Neurocrine Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Neurocrine Biosciences's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neurocrine Biosciences have currently?

Minus sign iconPlus sign icon
As of November 2024, Neurocrine Biosciences has approximately 1.7K employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: K. W. G.Chief Executive Officer: J. W.Chief Executive Officer: M. F.. Explore Neurocrine Biosciences's employee directory with LeadIQ.

What industry does Neurocrine Biosciences belong to?

Minus sign iconPlus sign icon
Neurocrine Biosciences operates in the Biotechnology Research industry.

What technology does Neurocrine Biosciences use?

Minus sign iconPlus sign icon
Neurocrine Biosciences's tech stack includes iCIMSVeeamMicrosoft WordMicrosoft PowerPointAMPscikit-learniOSLinux.

What is Neurocrine Biosciences's email format?

Minus sign iconPlus sign icon
Neurocrine Biosciences's email format typically follows the pattern of . Find more Neurocrine Biosciences email formats with LeadIQ.

When was Neurocrine Biosciences founded?

Minus sign iconPlus sign icon
Neurocrine Biosciences was founded in 1992.
Neurocrine Biosciences

Neurocrine Biosciences

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. 

Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines

*in collaboration with AbbVie

Section iconCompany Overview

Headquarters
San Diego, California US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
NBIX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1992
Employees
1001-5000

Section iconFunding & Financials

  • $1B

    Neurocrine Biosciences's revenue is in the range of $1B

Section iconFunding & Financials

  • $1B

    Neurocrine Biosciences's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.